These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 9165504
1. High-dose toremifene vs tamoxifen in postmenopausal advanced breast cancer. Gershanovich M, Hayes DF, Ellmén J, Vuorinen J. Oncology (Williston Park); 1997 May; 11(5 Suppl 4):29-36. PubMed ID: 9165504 [Abstract] [Full Text] [Related]
2. [Results of phase II clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women]. Gershanovich ML, Garin AM, Baltinia D, Kurvet A, Kangas L, Ellmen Iu. Vopr Onkol; 1997 May; 43(6):587-95. PubMed ID: 9479357 [Abstract] [Full Text] [Related]
3. Phase III trials of toremifene vs tamoxifen. Gams R. Oncology (Williston Park); 1997 May; 11(5 Suppl 4):23-8. PubMed ID: 9165503 [Abstract] [Full Text] [Related]
4. Open phase II study of high-dose toremifene as first-line therapy for advanced breast cancer. Hietanen T, Hakala T, Baltina D, Johansson R, Numminen S, Helle L, Valavaara R, Thölix E. Oncology (Williston Park); 1997 May; 11(5 Suppl 4):37-40. PubMed ID: 9165505 [Abstract] [Full Text] [Related]
5. Evolving role of toremifene in the adjuvant setting. Holli K. Oncology (Williston Park); 1997 May; 11(5 Suppl 4):48-51. PubMed ID: 9165507 [Abstract] [Full Text] [Related]
6. [Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer]. Yamamoto Y, Kawazoe T, Iwase H. Gan To Kagaku Ryoho; 2005 Oct; 32(10):1415-9. PubMed ID: 16227740 [Abstract] [Full Text] [Related]
8. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial. Tominaga T, Kimijima I, Kimura M, Takatsuka Y, Takashima S, Nomura Y, Kasumi F, Yamaguchi A, Masuda N, Noguchi S, Eshima N. Jpn J Clin Oncol; 2010 Jul; 40(7):627-33. PubMed ID: 20382637 [Abstract] [Full Text] [Related]
9. Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients. Tomás E, Kauppila A, Blanco G, Apaja-Sarkkinen M, Laatikainen T. Gynecol Oncol; 1995 Nov; 59(2):261-6. PubMed ID: 7590484 [Abstract] [Full Text] [Related]
11. Phase II and III clinical trials of toremifene for metastatic breast cancer. Vogel CL. Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):9-13. PubMed ID: 9556785 [Abstract] [Full Text] [Related]
13. Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment. Jönsson PE, Malmberg M, Bergljung L, Ingvar C, Ericsson M, Ryden S, Nilsson I, Terje IJ. Anticancer Res; 1991 Mar; 11(2):873-5. PubMed ID: 1829600 [Abstract] [Full Text] [Related]
15. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen. Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA. Cancer; 2008 Apr 01; 112(7):1437-44. PubMed ID: 18286526 [Abstract] [Full Text] [Related]
16. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Cohen MH, Johnson JR, Li N, Chen G, Pazdur R. Clin Cancer Res; 2002 Mar 01; 8(3):665-9. PubMed ID: 11895893 [Abstract] [Full Text] [Related]